Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05257889
Other study ID # 17101539
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 2022
Est. completion date October 2023

Study information

Verified date February 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A cross sectional study on neonatal seizures in Assuit University Children's hospital NICU.


Description:

An Overview on neonatal seizures in neonatal intensive care unit of Assuit University Children's hospital , a cross sectional study. The aim of this study is to evaluate the clinical seizures during the neonatal period and its prevalence


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 554
Est. completion date October 2023
Est. primary completion date August 2023
Accepts healthy volunteers
Gender All
Age group N/A to 1 Month
Eligibility Inclusion Criteria: - ALL neonates (preterm and full-term infants) aged 0 to 28 days who are admitted to the neonatal intensive care unit of Assiut University Children's hospital during the period of the study will be included Exclusion Criteria: - Neonates with multiple congenital anomalies (other than CNS anomalies)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
blood and CSF studies + neuroimaging studies
blood and CSF studies + neuroimaging studies

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary prevalence of neonatal seizures among neonates admitted to Assiut University children's hospital prevalence of neonatal seizures among neonates admitted to Assiut University children's hospital during period of study 1 year
Secondary number of patients with controlled seizures during hospital admission period Short term outcomes of clinical seizures (if seizures could be controlled during hospital admission period or not) 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05127070 - Evaluating the NeoTree in Malawi and Zimbabwe
Withdrawn NCT03602118 - Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures Phase 3
Not yet recruiting NCT04831242 - Monitoring Key Activity and Physiology of Neonates in Intensive Care
Completed NCT01224457 - Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients. N/A
Recruiting NCT05610085 - A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures Phase 2
Recruiting NCT05036395 - The Effect of AI-assisted cEEG Diagnosis on the Administration of Antiseizure Medication in Neonatal Seizures N/A
Withdrawn NCT04991779 - AI-assisted cEEG Diagnosis of Neonatal Seizures in Neonatal Intensive Care Unit
Recruiting NCT04337697 - Neonatal Seizure Registry - Developmental Functional EValuation
Withdrawn NCT03996317 - Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities N/A
Active, not recruiting NCT06308185 - Neonatal Seizures: Semiology, Etiology, Therapy and Prognosis Correlations
Not yet recruiting NCT03786497 - Protecting Brains and Saving Futures - the PBSF Protocol
Completed NCT06211192 - What Are the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures?
Completed NCT01747863 - Prospective Research in Infants With Mild Encephalopathy N/A
Active, not recruiting NCT04259125 - Evaluating the Role of Inflammation in Neonatal Epileptogenesis
Recruiting NCT05361070 - Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy